Source:http://linkedlifedata.com/resource/pubmed/id/16973387
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-9-18
|
pubmed:abstractText |
Transforming growth factor-beta (TGF-beta) has been implicated in the control of differentiation and proliferation of multiple cell types. However, a role for TGF-beta in the control of immune homeostasis is not fully understood because of its pleiotropic action. Here we report that complete ablation of the TGF-beta signaling in T cells engendered aggressive early-onset, multiorgan, autoimmune-associated lesions with 100% mortality. Peripheral CD4+ and CD8+ T cells with TGF-beta-receptor II (TGF-betaRII) deficiency activated cytolytic and T helper 1 (Th1) differentiation program in a cell-intrinsic T cell receptor (TCR)-specific fashion. Furthermore, TGF-betaRII deficiency blocked the development of canonical CD1d-restricted NKT cells. Instead, it facilitated generation of a highly pathogenic T cell subset exhibiting multiple hallmarks of NK cells and sharply elevated amounts of FasL, perforin, granzymes, and interferon-gamma. Thus, TGF-beta signaling in peripheral T cells is crucial in restraining TCR activation-dependent Th1, cytotoxic, and NK cell-like differentiation program which, when left unchecked, leads to rapidly progressing fatal autoimmunity.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/NK Cell Lectin-Like Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1074-7613
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
441-54
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16973387-Animals,
pubmed-meshheading:16973387-Antigens, Surface,
pubmed-meshheading:16973387-Autoimmune Diseases,
pubmed-meshheading:16973387-Cells, Cultured,
pubmed-meshheading:16973387-Immune Tolerance,
pubmed-meshheading:16973387-Lectins, C-Type,
pubmed-meshheading:16973387-Lymphocyte Depletion,
pubmed-meshheading:16973387-Mice,
pubmed-meshheading:16973387-Mice, Inbred C57BL,
pubmed-meshheading:16973387-Mice, Knockout,
pubmed-meshheading:16973387-Mice, Transgenic,
pubmed-meshheading:16973387-NK Cell Lectin-Like Receptor Subfamily B,
pubmed-meshheading:16973387-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:16973387-T-Lymphocytes,
pubmed-meshheading:16973387-Time Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor.
|
pubmed:affiliation |
Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle, Washington 98195, USA. marie@cervi-lyon.inserm.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|